One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-145572
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 29 |
Affiliation: Allogene Therapeutics (United States), The University of Texas MD Anderson Cancer Center, Mayo Clinic, Cleveland Clinic, Vanderbilt University Medical Center, Colorado Blood Cancer Institute, City Of Hope National Medical Center, Memorial Sloan Kettering Cancer Center, Medical College of Wisconsin, Mount Sinai Medical Center, Massachusetts General Hospital, Stanford University, St David's Medical Center, Sarah Cannon, CHRISTUS Transplant Institute, Hackensack University Medical CenterUniversal Updated Phase 1 Data Validates the Feasibility of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
